|
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB | |
Other (Supporting Information)
2MB |
Item Type: | Letter |
---|---|
Title: | Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene-edited human-induced pluripotent stem cell-derived cardiomyocytes and preclinical drug screening |
Creators Name: | El-Battrawy, I. and Lan, H. and Cyganek, L. and Maywald, L. and Zhong, R. and Zhang, F. and Xu, Q. and Lee, J. and Duperrex, E. and Hierlemann, A. and Saguner, A.M. and Duru, F. and Kovacs, B. and Huang, M. and Liao, Z. and Albers, S. and Müller, J. and Dinkel, H. and Rose, L. and Hohn, A. and Yang, Z. and Qiao, L. and Li, Y. and Lang, S. and Kleinsorge, M. and Mügge, A. and Aweimer, A. and Fan, X. and Diecke, S. and Akin, I. and Li, G. and Zhou, X. |
Keywords: | Brugada Syndrome, Cardiac Death, Channelopathy, Short QT Syndrome |
Source: | Clinical and Translational Medicine |
ISSN: | 2001-1326 |
Publisher: | Wiley |
Volume: | 11 |
Number: | 12 |
Page Range: | e646 |
Date: | 26 December 2021 |
Official Publication: | https://doi.org/10.1002/ctm2.646 |
PubMed: | View item in PubMed |
Repository Staff Only: item control page